# Mantra Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mantra-bio

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.mantrabio.com
- Total disclosed funding: $39M
- Latest round: Series A (Jan 4, 2023)
- Investors on record: 6

## About

Mantra Bio, Inc. specializes in the development of innovative software solutions aimed at enhancing operational efficiency and user experience across various industries, including technology and healthcare.Founded in 2016 and headquartered in South San Francisco, US, Mantra Bio, Inc. focuses on creating advanced technology solutions. The company has completed 2 deals, with its most recent funding round occurring on January 4, 2023. In this Series A round, they raised USD 9.000 mn from investors including Samsung Securities and returning members such as 8VC, Allen & Company, and Illumina Ventures. The company was co-founded by Alex Mok, Katie Planey, and Terry Gaige, with Alex Mok currently serving as CEO.Mantra Bio, Inc. offers a range of specialized products and services designed to address specific challenges within its target markets. Their core offerings include innovative software solutions that enhance operational efficiencies and improve user experiences. These products cater to a diverse clientele, from small to medium-sized enterprises to large corporations across technology, healthcare, and finance industries. The solutions released over the past few years focus on enhancing productivity, data management, and analysis capabilities, allowing users to make informed decisions and optimize workflows. The company has established a presence in North America, Europe, and parts of Asia, serving businesses that seek advanced technological tools to maintain competitiveness.Mantra Bio, Inc. generates revenue through a combination of subscription-based models and direct sales of its flagship products. Transactions typically occur on a B2B basis, with clients entering annual contracts for software access and customer support. These contracts often feature tiered pricing structures, enabling clients to select plans that meet their specific needs and operational scale. Larger enterprises can opt for comprehensive packages with multiple software licenses and premium features, while smaller firms may choose basic plans tailored to their requirements. This structured pricing approach fosters long-term client relationships and ensures a steady revenue stream, supporting the company's growth and product development efforts.Looking ahead, Mantra Bio, Inc. plans to utilize the USD 9.000 mn raised in the Series A funding round to further develop its product offerings. The company is focused on designing and launching new software solutions, although specific release dates have not been mentioned. Additionally, Mantra Bio is targeting expansion into new geographic markets, with plans to enter additional regions in North America and Europe by 2024. This strategic growth will allow the company to enhance its reach and better serve the evolving needs of its clients.

## Funding rounds

- Series A, Jan 4, 2023, $9M — Allen & Company, Viking Global Investors, BoxGroup, 8VC, Illumina Ventures, Samsung Securities
- Series A, Nov 19, 2019, $30M — Allen & Company, Viking Global Investors, BoxGroup, 8VC

## Investors

- Allen & Company — Series A
- Viking Global Investors (https://capitalatlas.ai/funds/viking-global-investors) — Series A
- BoxGroup (https://capitalatlas.ai/funds/boxgroup) — Series A
- 8VC (https://capitalatlas.ai/funds/8vc) — Series A
- Illumina Ventures (https://capitalatlas.ai/funds/illumina-ventures) — Series A
- Samsung Securities — Series A